hVIVO plc Notice of Interim Results (9535X)
August 16 2018 - 1:01AM
UK Regulatory
TIDMHVO
RNS Number : 9535X
hVIVO plc
16 August 2018
hVIVO plc
("hVIVO" or the "Company")
Notice of Interim Results
London, UK, 16 August 2018: hVIVO plc (AIM: HVO), a pioneer of
human disease models and an industry leading clinical development
services business, will announce its interim financial results for
the six months ended 30 June 2018 on Thursday 20 September
2018.
A presentation and webcast for analysts will be held at 9.00am
BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate
Street, London, EC1A 4HD, with registration and coffee from 8.45am.
A webcast recording of the event will be available on the Company's
website.
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Graham Yeatman (Chief Financial
Officer)
Fleur Wood (Director, Investor Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Michael Burke (Corporate
Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based analytical
platform to accelerate drug discovery and development in
respiratory and infectious diseases. Leveraging human disease
models in flu, RSV and asthma exacerbation, the hVIVO platform
captures disease in motion, illuminating the entire disease life
cycle from healthy to sick and back to health. Based in the UK,
market leader hVIVO has conducted more than 50 clinical studies,
inoculated over 2500 volunteers and has three first-in-class
therapies currently in development.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORLFFFLTVIELIT
(END) Dow Jones Newswires
August 16, 2018 02:01 ET (06:01 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From Sep 2023 to Sep 2024